Section Arrow
LIVN.NASDAQ
- LivaNova PLC
Quotes are at least 15-min delayed:2025/02/01 12:01 EST
Last
 49.933
-0.707 (-1.40%)
Day High 
51.08 
Prev. Close
50.64 
1-M High
52.08 
Volume 
598.19K 
Bid
48.88
Ask
50.83
Day Low
49.815 
Open
50.31 
1-M Low
45.75 
Market Cap 
2.75B 
Currency USD 
P/E 117.77 
%Yield -- 
10-SMA 49.25 
20-SMA 48.23 
50-SMA 49.35 
52-W High 64.475 
52-W Low 43.15 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.43/2.43
Enterprise Value
3.36B
Balance Sheet
Book Value Per Share
24.13
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
1.08B
Operating Revenue Per Share
20.59
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SENSSenseonics Holdings0.9608-0.1292-11.85%-- 
QSIQuantum-Si1.98+0.02+1.02%-- 
PACBPacific Biosciences of California1.54-0.06-3.75%-- 
MDTMedtronic plc90.82-1.17-1.27%28.13PE
ABTAbbott Laboratories127.93-0.88-0.68%39.2PE
Quotes are at least 15-min delayed:2025/02/01 12:01 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.